Multidisciplinary approach in the treatment of spin diseases

The article discusses the method of multidisciplinary treatment of patients with a diagnosis of M54.5 "Low back pain" based on the combined use of physiotherapy, kinesitherapy and correction of anxious depression. It was established that treatment of patients with lower back pain based on the proposed method reduces the level of subjective assessment of pain according to the VAS scale by 28 ± 3% reduces the clinical manifestations of pain and by 21 ± 4% the level of depression according to A. Beck's psychometric table compared to the control group

Results of implementation of viral hepatitis B elimination program in the North-West Russia

Introduction. Vaccination contributed to reduce the incidence of acute hepatitis B in the territories of the North-West Russia. The urgency of this problem remains due to the high incidence of chronic hepatitis B. This accounted for the need to develop a hepatitis B elimination program in the district discussed that was approved in 2013 by the head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. Objective is to characterize the results of the program for the elimination of acute hepatitis B virus implemented in the North-Western Federal District. Materials and methods. The 2010–2020 incidence rate of acute and chronic hepatitis B virus (HBV) infection in the regions of the North-West Russia was carried out. To determine HBV genotypes and subgenotypes, 160 blood plasma samples from patients with acute hepatitis B were studied using molecular genetic methods (PCR, sequencing). The prevalence of latent hepatitis B in various population groups was assessed. The 2016–2020 hepatitis B vaccination coverage and relevant serological monitoring in adults was carried out. Results. While implementing the program, it was found that the incidence rate of acute hepatitis B in the district decreased by 4.5-fold, revealing in 2020 no cases of the disease in 5 regions, with incidence rate in the 6 subfederal units being lower than 1.0 per 100,000 population. Moreover, the incidence rate for chronic hepatitis B decreased by 2.6 times. The 2020 vaccination coverage of children under 17 and adults in all territories comprised more than 95% and 90%, respectively. In addition, it was shown the circulation of genotypes D and A of hepatitis B virus is dominated by genotype D (91.8%), subgenotype D2 (47.8%). The prevalence of latent hepatitis B among migrants was 6.5%, pregnant women — 4.9%, hemodialysis patients — 1.7%. Conclusion. Implementation of the program on elimination of acute viral hepatitis B in the territory of the North-West Russia contributed to raise in the vaccination coverage in adult population and lowered incidence rate of acute and chronic HBV infection

Combined application of ultrasonic waves, magnetic fields and optical flow in the rehabilitation of patients and disabled people

SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION PONTIFICAL CATHOLIC UNIVERSITY OF PERU RADOM UNIVERSITY SCM «MEDICAL INNOVATIVE TECHNOLOGIES» Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. COMBINED APPLICATION OF ULTRASONIC WAVES, MAGNETIC FIELDS AND OPTICAL FLOW IN THE REHABILITATION OF PATIENTS AND DISABLED PEOPLE Edited by Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. КIEV, RADOM 2016 SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION PONTIFICAL CATHOLIC UNIVERSITY OF PERU RADOM UNIVERSITY SCM «MEDICAL INNOVATIVE TECHNOLOGIES» Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. COMBINED APPLICATION OF ULTRASONIC WAVES, MAGNETIC FIELDS AND OPTICAL FLOW IN THE REHABILITATION OF PATIENTS AND DISABLED PEOPLE Edited by Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. КIEV, RADOM 2016 Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Combined Application of Ultrasonic Waves, Magnetic Fields and Optical Flow in The Rehabilitation of Patients and Disabled People. Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Eds. Shupyk National Medical Academy of Postgraduate Education. Pontifical Catholic University of Peru. Radom University. SCM «Medical Innovative Technologies». Kiev. Radom. 308 p. ISBN 9781365244537. DOI http://dx.doi.org/10.5281/zenodo.57246 UDC 615.847.8+615.837 LBC: 53.54 Reviewers: prof. zw. dr hab. med. L. Tondiy (Ukraine), MD, Professor L. Tondiy prof. zw. dr hab. med. V. Gubenko (Ukraine), MD, Professor V. Gubenko prof. zw. dr hab. med. A. Kozhanova (Ukraine), MD, Professor A. Kozhanova Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Combined application of ultrasonic waves, magnetic fields and optical flow in the rehabilitation of patients and disabled people. Edited by Chukhraiev N., Vladimirov А., Vilcahuamаn L., Zukow W., Samosyuk N., Chukhraieva E., Butskaya L. Kiev. Radom. – 2016. – 308 p. UDC 615.847.8+615.837 LBC: 53.54 Memory of the great scientist Professor Ivan Zakharovich Samosyuk dedicated. The book presents modern data on the use of a resonant magnetic therapy, ultrasound and magnetic-laser effects. Describes practical techniques of the combined and the united use of these physical factors in the different sections of clinical medicine (neurology, cardiology, gastroenterology, gynecology, etc.). The book also describes the modern principles of selecting impact zones, the rationale biorhythmological and resonance effects, the practical use of which is becoming increasingly important in physiotherapy and physiopuncture. Most private techniques of magnet-laser-ultrasound therapy are described with respect to a new generation of devices of «MIT» series and the «MIT-11», which contains all three of these factors: ultrasound, magnetic field and laser radiation. The book is intended for physical therapists, rehabilitation specialists, health resort, the doctors of narrow specialties, using methods of physiotherapy, as well as nurses rehabilitation centers, beauty parlor and a wide range of readers interested in the problems of sanitation. Authors are grateful to Alla Tereshchenko, Yevheniya Gorlatenko and Olga Danilova for their assistance in the preparation for publication of the monograph. © The Author(s) 2016. This articles is published with Open Access. Medical Innovative Technologies, Kiev, Ukraine and Radomska Szkoła Wyższa w Radomiu, Poska, Radom University in Radom, Poland. Open Access This articles is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. Attribution — You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of the work). Noncommercial — You may not use this work for commercial purposes. Share Alike — If you alter, transform, or build upon this work, you may distribute the resulting work only under the same or similar license to this one. Zawartość jest objęta licencją Creative Commons Uznanie autorstwa-Użycie niekomercyjne-Na tych samych warunkach 3.0 Publishing House: Radomska Szkoła Wyższa w Radomiu, Radom University in Radom Str. Zubrzyckiego 2 26-600 Radom Tel.: +48 48 383 66 05 [email protected] Printing House: Radomska Szkoła Wyższa w Radomiu, Radom University in Radom Str. Zubrzyckiego 2 26-600 Radom Tel.: +48 48 383 66 05 [email protected] ISBN 9781365244537 DOI http://dx.doi.org/10.5281/zenodo.57246 308 s. Liczba znaków: 478 000 (ze streszczeniami i okładką). Liczba grafik: 136 x 1 000 znaków (ryczałt) = 136 000 znaków. Razem: Liczba znaków: 614 000 (ze streszczeniami, okładką i grafikami) = 15,35 arkuszy wydawniczych. 308 p. Number of characters: 248 000 (with abstracts). Number of images: 136 x 1000 characters (lump sum) = 136 000 characters. Total: Number of characters: 614 000 (with abstracts, summaries and graphics) = 15,35 sheet publications. CONTENT ABBREVIATIONS............................................................................................. 8 INTRODUCTION............................................................................................... 9 Modern principles of choice of impact zones in the physiotherapy treatment..... 10 Lets speak more detail on the possible areas of choice for PT................................ 10 Zones of Zakhary’in-Ged and metameric segmental principle of choosing zones in physiotherapy...................................................................... 11 The systemic principle of the human body functions organization and the selection of treatment zones, based on this principle.............................. 15 Special and specific zones of influence and choice in the practice of physical therapy............................................................................ 21 Lumbar region...................................................................................................... 21 The area of cervical spine...................................................................................... 21 The trans-cerebral techniques............................................................................... 22 Biological rhythms and bioresonance therapy...................................................... 26 Ultrasound therapy............................................................................................... 47 Basic terms and concepts...................................................................................... 49 Features of action of ultrasonic waves on the body............................................... 52 The therapeutic effect of ultrasound waves*........................................................ 53 The methods and techniques of treatment with ultrasonic waves........................ 57 Ultrasound therapy (UST).................................................................................... 58 Ultraphonophoresis (UPPh)................................................................................. 58 Sonopuncture (SP)............................................................................................... 61 A combination of other health factors with sonopuncture................................... 65 The combination of the action of ultrasonic waves with other physical factors ... 65 Indications and contraindications to the use of ultrasound therapy.............................................. 66 The main indications for ultrasound therapy........................................................ 66 Main contraindications......................................................................................... 67 Prohibited areas for ultrasonic therapy................................................................. 67 Features of ultrasound therapy............................................................................. 68 Nota bene for doctor and patient......................................................................... 69 Magnetic-laser therapy......................................................................................... 69 Therapeutic effects of magnetic laser therapy (MLT)........................................... 72 General principles of magneto-laser therapy........................................................ 78 Here are some options for MLT and features of their use.................................... 79 Percutaneous magnetic laser irradiation of blood................................................ 80 The zone for exposure to magnetic percutaneous laser irradiation of the blood . 82 Parameters of the procedure of hemo-magnetic-laser-therapy........................................................................... 82 The combined and united use of physical factors.................................................. 84 REFERENCES.................................................................................................... 88 PRACTICAL RECOMMENDATIONS FOR USE OF MAGNET-LASER-ULTRASOUND THERAPY IN CLINICAL PRACTICE AND THE SPA ................................................................................ Contraindications................................................................................................. 92 К00-К93 Diseases of the digestive system........................................................... 94 K50-K52 NONINFECTIOUS Enterocolitis and colitis...................................... 94 K29 GASTRITIS, DUODENITIS...................................................................... 96 K25 Gastric ulcer.................................................................................................. 98 K26 Duodenal Ulcer............................................................................................ 98 K71 LIVER TOXICITY..................................................................................... 100 К70 K70 CHRONIC HEPATITIS..................................................................... 102 К82.8 DYSKINESIA OF CYSTIC DUCT OR GALLBLADDER.................... 104 К 86.0 CHRONIC PANCREATITIS................................................................. 106 K81 CHOLECYSTITIS (non-calculous)............................................................ 108 К 59.0 CONSTIPATION (Other functional intestinal disorders)...................... 110 J00-J99 RESPIRATORY DISEASES............................................................................... 112 A15-A19 PULMONARY TUBERCULOSIS.................................................... 112 J42 CHRONIC BRONCHITIS UNSPECIFIED.............................................. 114 J18 PNEUMONIA............................................................................................. 116 J.45 BRONCHIAL ASTHMA............................................................................ 118 J01 ACUTE SINUSITIS (ANTRITIS)............................................................... 120 J01 ACUTE SINUSITIS (FRONTAL SINUSITIS)........................................... 122 J03 ACUTE TONSILLITIS................................................................................ 124 J00 ACUTE NASOPHARYNGITIS (RHINITIS)............................................. 126 J31.2 CHRONIC PHARYNGITIS.................................................................... 128 J37 CHRONIC LARYNGITIS AND TRACHEITIS......................................... 130 Н65- Н66 CHRONIC SUPPURATIVE OTITIS MEDIA................................ 132 H81.0 MÉNIÈRE’S DISEASE, SENSORINEURAL HEARING LOSS...................................... 134 K00-K14 DISEASES OF ORAL CAVITY,....................................................... 136 SALIVARY GLANDS AND JAWS......................................................................................... 136 М19.2- М24.6 ARTHROSIS OF THE TEMPOROMANDIBULAR JOINT..... 138 N00-N99 DISEASES OF THE GENITOURINARY SYSTEM........................ 140 F98 ENURESIS.................................................................................................. 140 N48.4 IMPOTENCE.......................................................................................... 142 N41.1 CHRONIC PROSTATITIS..................................................................... 144 N34 URETHRITIS AND URETHRAL SYNDROME...................................... 146 N11 CHRONIC PYELONEPHRITIS............................................................... 148 N20-N23 UROLITHIASIS................................................................................ 150 O00-O99 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM........... 152 O92.1 CRACKED NIPPLES............................................................................. 152 MAIN POINTS OF ACUPUNCTURE IN GYNECOLOGY........................... 154 N61 MASTITIS................................................................................................. 154 N70.1 CHRONIC ADNEXITIS........................................................................ 156 N71 ENDOMETRITIS...................................................................................... 158 N94 ALGOMENORRHEA............................................................................... 160 N91.0- N91.1 AMENORRHEA........................................................................ 162 N73 INFLAMMATORY DISEASES OF THE PERITONEUM AND TISSUES OF THE SMALL PELVIS...................................................... 164 N86 CERVICAL EROSION............................................................................. 166 N90.5 KRAUROSIS OF THE VULVA.................................................................................. 168 N89 VAGINAL DISCHARGE......................................................................... 170 N97 INFERTILITY........................................................................................... 172 О12- О14- О15 GESTATIONAL TOXICOSIS (GESTOSES)......................... 174 I99 DISEASES OF THE CIRCULATORY SYSTEM................................ 176 I10 HYPERTENSIVE HEART DISEASE....................................................... 176 I22 MYOCARDIAL INFARCTION................................................................ 178 I49 EXTRASYSTOLE (OPTION 1).................................................................. 180 I49 EXTRASYSTOLE (OPTION 2).................................................................. 182 E10-E14 DIABETES.......................................................................................... 184 I20-I25 CORONARY HEART DISEASE........................................................ 186 E06.3 AUTOIMMUNE THYROIDITIS........................................................... 189 I63 ISCHEMIC STROKE................................................................................. 191 G43 MIGRAINE............................................................................................... 194 N00-H59 DISEASES OF THE EYE AND ADNEXA...................................... 196 H47.0 OPTIC NERVE SUBATROPHY.......................................................... 196 H35 RETINITIS PIGMENTOSA...................................................................... 196 H00-H59 MYOPIA............................................................................................ 198 Н 36.0 DIABETIC RETINOPATHY................................................................ 200 L00-L99 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE....... 203 L40 PSORIASIS................................................................................................ 203 L43 RED FLAT ZOSTER.................................................................................. 205 L20-L30 DERMATITIS AND ECZEMA......................................................... 207 B00 B00 INFECTION CAUSED BY THE HERPES VIRUS (HERPES SIMPLEX)........................................................................................ 210 L20.8 NEURODERMATITIS........................................................................... 212 L94.0 LOCALIZED SCLERODERMA............................................................ 214 SURGICAL DISEASES.................................................................................... 216 К65 PERITONITIS........................................................................................... 216 L91.0 KELOIDS (PREVENTION SUPPURATION)...................................... 218 T79.3 POST-TRAUMATIC WOUND INFECTION, NOT ELSEWHERE CLASSIFIED................................................................... 220 FESTERING WOUNDS................................................................................... 220 L02 ABSCESSES, BOILS, CARBUNCLES.................................................... 222 L03 PHLEGMON, FELON............................................................................... 222 E14.5 TROPHIC ULCERS................................................................................ 224 I80 PHLEBITIS AND THROMBOPHLEBITIS.............................................. 226 А46 ERYSIPELAS............................................................................................ 228 T20-T32 THERMAL AND CHEMICAL BURNS............................................ 230 M42 OSTEOCHONDROSIS............................................................................ 232 M54.4 4 LUMBAGO WITH SCIATICA.......................................................... 234 R52 CHRONIC PAIN SYNDROME................................................................ 236 M60.0 MYO FASCIITIS................................................................................... 238 M62.8 MIOFIBROZIT...................................................................................... 238 M79.0 FIBROSIS; FIBROMYALGIA;............................................................ 238 M72.5 FASCIITIS.............................................................................................. 238 M00-M99 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE......................................................... 240 M 00 - M 03 INFECTIOUS ARTHROPATHIES............................................. 240 M05-M14 INFLAMMATORY POLYARTHROPATHIES............................. 242 (RHEUMATOID ARTHRITIS)........................................................................ 242 М15-М 19 DEFORMING ARTHROSIS.......................................................... 244 М10-М14 ARTHRITIS GOUTY....................................................................... 246 K07 DISEASES OF THE TEMPOROMANDIBULAR JOINT....................... 248 K07.6 CALCANEAL SPUR.............................................................................. 250 М 65.2 CALCIFYING TENDOVAGINITIS................................................... 252 М45. BEKHTEREV’S DISEASE (ANKYLOSING SPONDYLITIS)............ 254 M24 DUPUYTREN’S CONTRACTURE......................................................... 256 M81 OSTEOPOROSIS...................................................................................... 258 G00-G99 DISEASES OF THE NERVOUS SYSTEM...................................... 260 G51 NEURITIS OF THE FACIAL NERVE..................................................... 260 G50 DAMAGE OF THE TRIGEMINAL NERVE........................................... 262 Ultrasound puncture........................................................................................... 264 М79.2 INTERCOSTAL NEURALGIA............................................................ 265 Ultrasound puncture........................................................................................... 267 M79.2 NEURALGIA OF CERVICAL DEPARTMENT OF THE BACKBONE .. 268 M79.2 NEURALGIA OF THE LUMBAR SPINE...................................................................................... 270 Т75.2 VIBRATION DISEASE.......................................................................... 272 M60 MYOSITIS................................................................................................. 274 ULTRASONIC PUNCTURE IN MYOSITIS:.................................................. 275 F00-F99 MENTAL AND BEHAVIORAL DISORDERS................................ 276 F51.0 INSOMNIA............................................................................................. 276 F32 DEPRESSION............................................................................................ 278 F40-F48 NEUROTIC, STRESS-RELATED AND SOMATOFORM DISORDERS........................................................................ 280 Е65-Е68 OBESITY AND OTHER TYPES OF HYPERNUTRITION............. 282 F01.1 MULTI-INFARCT DEMENTIA............................................................. 284 I 15 VEGETATIVE DYSTONIA (VD) ON HYPERTENSIVE TYPE............ 286 G21 PARKINSON’S DISEASE........................................................................ 288 F90 DYSTONIC HYPERKINESIA (TORTICOLLIS,.................................... 290 OROMANDIBULAR DYSKINESIA)............................................................. 290 APPLICATION OF MAGNET-LASER ULTRASOUND THERAPY FOR HEALTH IMPROVING AND PREVENTIVE PURPOSES 292 Annex 1..